Skip to main content
Hits: 677
28 Δεκεμβρίου 2003
Κατηγορία
Οσφυαλγία
# Topics
Follow Us
Social sharing

Medium-Firm Mattress May Improve Low-Back Pain

A medium-firm mattress improves pain and disability among patients with chronic nonspecific low-back pain, according to the results of a randomized, double-blind, controlled multicenter trial. The study was published in the Nov. 15 issue of The Lancet.

Mindy Hung 
Medscape Medical News 2003. © 2003 Medscape


Nov. 13, 2003 — A medium-firm mattress improves pain and disability among patients with chronic nonspecific low-back pain, according to the results of a randomized, double-blind, controlled multicenter trial. The study was published in the Nov. 15 issue of The Lancet.

strwma

"In daily practice, physicians are frequently requested to counsel on the characteristics of beds and mattresses to lessen back pain," write Francisco M. Kovacs, PhD, and colleagues from the Scientific Department of the Kovacs Foundation, in Palma de Mallorca, Spain.

"In a survey of orthopaedic surgeons, 95% believed that mattresses played a part in the management of low-back pain, with 76% recommending a firm mattress. However, evidence supporting this advice is lacking."

Investigators drew 313 subjects from a previous population-based study on the prevalence and risk factors for common low-back pain in adolescents and their parents. Patients were eligible for study if they were aged 18 years or older; reported chronic low-back pain for three months or more without referred pain, presence of pain while lying in bed or on rising.

Investigators excluded patients with habitual prostration, signs of possible systemic disease, inflammatory disease or cancer, diagnosis or clinical suspicion of fibromyalgia, or pregnancy. They also did not include patients who habitually slept in a different bed two or more nights per week, those taking anti-inflammatory medication with a 24-hour effect at any time of the day, and those taking hypnotic, analgesic, anti-inflammatory, or relaxant medication for any reason from 1700 hours to the time at which pain on rising was assessed.

Subjects did not discontinue daytime medications for low-back pain. For participants who shared beds, only one person using the bed was allowed to participate.

Investigators used the European Committee for Standardization Scale to rate mattress firmness (HS), with 1.0 being the firmest and 10.0 being the softest. One-hundred fifty-eight participants received a firm mattress (HS 2-3), and 155 participants received a medium-firm mattress (HS 5-6).

Participants did not know that two different kinds of mattresses were going to be compared. They were told they could withdraw from the study if the new mattress made their pain worse.

Patients were assessed in their homes at baseline and at 90 days by a research assistant who recorded variables that might affect the clinical course of low-back pain, including age, sex, weight, exposure to repeated flexion-extension movements with load or whole-body vibration at work, most common sleeping position, and number of minutes in bed daily.

Patients also self-assessed intensity of pain while lying in bed, the intensity of pain on rising, and the degree of disability using a visual analogue scale, which ranges from zero (least) to 10 (most intense pain).

Patients rated their pain as soon as they woke up (pain while lying in bed) and within 30 minutes of rising (pain on rising). They also evaluated disability through a Spanish version of the Roland Morris questionnaire, consisting of 24 items related to activities of daily living. Scores range from zero (no disability) to 24 (maximum disability).

At 90 days, subjects also reported their subjective feeling on firmness of the new mattress, whether their partner had pain in bed, use of medication for low-back pain, daily low-back pain, low-back pain while lying in bed and on rising throughout the study (follow-up period), and whether subjects experienced more pain in bed when more time was spent in it.

Intensity of pain while lying in bed and on rising along with the degree of disability were the primary outcomes. Low-back pain, low-back pain in bed or on rising throughout the course of the study, and more intense pain in bed when lying down were among secondary outcomes.

A change of mattress was associated for most patients with improvement in pain while lying in bed (firm mattress, 77.8% vs. 82.6% for medium-firm mattress; odds ratio [OR], 1.35 [95% confidence interval [CI], 0.77 - 2.36]; P = .29) and when rising (80.4% vs. 85.8%; OR, 1.48 [CI, 0.81 - 6.68]; P = .201).

Participants with medium-firm mattresses had significantly better outcomes for pain in bed (OR, 2.36 [95% CI, 1.13 - 4.93]), pain on rising (OR, 1.93 [95% CI, 0.97-3.86]), and disability (OR, 2.10 [95% CI, 1.24 - 3.56]) than did patients with firm mattresses. Participants with medium-firm mattresses also reported less daytime low-back pain (P = .059), pain while lying in bed (P = .064), and pain on rising (P = .008) than did patients with firm mattresses.

The investigators acknowledged that the study design prevented them from quantifying the Hawthorne and placebo effects on the observed improvement. They noted that the effect of the firmness of the mattress on referred pain as well as on an acute exacerbation of backache was not known.

Dr. Kovacs and colleagues also note that although they used mattresses of two different firmnesses, they were spring mattresses and that while the firmness scale was independent of the composition of the mattress, results might differ with other kinds of mattresses.

"The medium-firm mattress was associated with an improvement in disability related to low-back pain," the investigators write. "This effect is particularly important since, although some cognitive and psychosocial interventions slightly improve the degree of disability, very few medical or physical interventions have achieved this objective.

"The results of this study also suggests [sic] that, although psychosocial factors have an effect on disability, some biomechanical factors that were not previously considered may also have an effect and should be taken into consideration for future studies," the authors conclude.

Lancet. 2003;362:1599-1604

Reviewed by Gary D. Vogin, MD

Τελευταία άρθρα

ΤΕΝΟΝΤΟΠΑΘΕΙΑ ΣΤΗΝ ΠΕΡΙΟΧΗ ΤΟΥ ΙΣΧΙΟΥ
| Χαράλαμπος Τιγγινάγκας MSc, Υπ. Διδάκτορας | Κάτω άκρα

Οι παθήσεις των τενόντων στην περιοχή τού ισχίου συχνά οδηγούν σε πόνο και λειτουργικό περιορισμό.

Η ΣΧΕΣΗ ΤΗΣ ΠΡΟΣΛΗΨΗΣ ΝΕΡΟΥ – ΗΜΙΚΡΑΝΙΑΣ
| Χαράλαμπος Τιγγινάγκας MSc, Υπ. Διδάκτορας | Πονοκέφαλος - Ημικρανίες

Υπάρχουν σαφείς ενδείξεις ότι η συστηματική πρόσληψη νερού συνδέεται με τη μείωση των επεισοδίων της ημικρανίας.

ΜΥΟΣΚΕΛΕΤΙΚΕΣ ΔΙΑΤΑΡΑΧΕΣ: ΠΡΟΒΛΕΨΕΙΣ ΕΩΣ ΤΟ 2050
| Χαράλαμπος Τιγγινάγκας MSc, Υπ. Διδάκτορας | Μυοσκελετικού Συστήματος

Οι μυοσκελετικές παθήσεις είναι υπεύθυνες για την αλλαγή στην ποιότητα της ζωής τών ασθενών. Πώς θα εξελιχθούν οι μυοσκελετικές διαταραχές έως το 2050;

ΔΙΑΤΑΡΑΧΗ ΣΤΗ ΣΤΑΣΗ ΤΟΥ ΣΩΜΑΤΟΣ
| Χαράλαμπος Τιγγινάγκας MSc, Υπ. Διδάκτορας | Σκέψεις

Η διαταραχή τής στάσης μπορεί να θεωρηθεί ως θέμα των ιστών εξαιτίας τάσης, τραύματος, ή συνδρόμου καταπόνησης, αλλά, τελικά, είναι ενδεικτικό ανεπάρκειας στο λογισμικό -software- τού εγκεφάλου.

ΚΡΑΝΙΟΪΕΡΗ ΘΕΡΑΠΕΙΑ ΓΙΑ ΤΗΝ ΗΜΙΚΡΑΝΙΑ (ΕΡΕΥΝΑ)
| Χαράλαμπος Τιγγινάγκας MSc, Υπ. Διδάκτορας | Πονοκέφαλος - Ημικρανίες

Η αντιμετώπιση της ημικρανίας είναι ένα σοβαρό πρόβλημα που απασχολεί τόσο τους ασθενείς, όσο και τους επιστήμονες υγείας.

ΟΣΤΕΟΡΘΡΙΤΙΔΑ ΚΑΙ ΣΥΝΤΗΡΗΤΙΚΗ ΘΕΡΑΠΕΙΑ
| Χαράλαμπος Τιγγινάγκας MSc, Υπ. Διδάκτορας | Οστεοαρθρίτιδα

Η οστεοαρθρίτιδα αποτελεί μια σύνθεση βιολογικών, γενετικών και περιβαλλοντικών παραγόντων. Η εμβάθυνση στην επιστημονική κατανόηση της νόσου είναι κρίσιμη για τη βελτίωση της ποιότητας ζωής των ασθενών.

ΠΡΩΙΜΗ ΕΝΑΡΞΗ ΦΥΣΙΚΟΘΕΡΑΠΕΙΑΣ ΣΤΗΝ ΟΣΦΥΑΛΓΙΑ
| Χαράλαμπος Τιγγινάγκας MSc, Υπ. Διδάκτορας | Σκέψεις

Στην οσφυαλγία και την ισχιαλγία, η πρώιμη έναρξη φυσικοθεραπευτικού προγράμματος αποκατάστασης είναι κρίσιμη για την αποτελεσματικότητα της θεραπείας.

ΣΥΝΔΡΟΜΟ ΘΩΡΑΚΙΚΗΣ ΕΞΟΔΟΥ - Ανασκόπηση
| Χαράλαμπος Τιγγινάγκας MSc, Υπ. Διδάκτορας | Σύνδρομο Θωρακικής εξόδου

Το σύνδρομο θωρακικής εξόδου είναι μία από τις πιο αμφιλεγόμενες κλινικές καταστάσεις στην ιατρική. 

Η ΜΑΧΗ ΕΝΑΝΤΙΑ ΣΤΗ ΒΑΡΥΤΗΤΑ
| Χαράλαμπος Τιγγινάγκας MSc, Υπ. Διδάκτορας | Στάση σώματος / Λειτουργικότητα

Οι επιπτώσεις από την δύναμη της βαρύτητας είναι συνδεδεμένες με τις αλλαγές στην ευθυγράμμιση του σκελετού και την εμφάνιση του πόνου. Η σωστή λειτουργία τού εγκεφάλου μάς προφυλάσσει, για άλλη μια φορά!

ΣΤΑΔΙΑ ΤΗΣ ΜΑΘΗΣΗΣ
| Χαράλαμπος Τιγγινάγκας MSc, Υπ. Διδάκτορας | Πληροφορίες για τον Εγκέφαλο

Η γνώση είναι ζωτικής σημασίας για τη σύγχρονη κοινωνία. Σε αντίθεση με τους προγόνους μας, ο κόσμος μας εκτιμά τη διανοητική ικανότητα πολύ περισσότερο από τη σωματική ικανότητα και έτσι η ανάγκη απόκτησης γνώσεων είναι πλέον ύψιστης σημασίας.